Magen H, Avigdor A, Nevo L, Fried S, et al. Anti-RBD IgG antibodies and neutralizing antibody levels after the second BNT162b2 dose in patients with plasma cell disorders. PLoS One 2023;18:e0284925.
PMID: 37126496